17:00 – Welcome Message
17:00 – 19:00 – Moderator: Dr Mircea Dediu
17.00 – 17.30 – New concepts of immune checkpoint inhibitor treatment: is neoadjuvant therapy an option and why? – Univ. Prof. Dr. Christoph Zielinski
17.30-19.00 Breast cancer
17.30 – 18.00 – CDK4/6 in metastatic breast cancer – is it standard treatment for all metastatic ER+ patients? – Dr. Larisa Ciule
18.00 – 18.30 – Radiation therapy in breast conserving strategies – Conf. Dr. Laura Rebegea
18.30 – 19.00 – Escalating and deescalating neo/adjuvant treatment in Her2 + breast cancer– Dr Mircea Dediu
19.00– – 19.15 – BREAK
19.15 – 20.00 – Other gynecological cancers – Moderator: Prof. Dr. Rodica Anghel
19.15 – 19.35 – Ovarian cancer – what is new in 2020? – Sef de lucrări Dr. Oana Trifănescu
19.35 – 20.00 – Cervical cancer – radiation therapy in the modern era – Prof. Dr. Rodica Anghel
20.00 – 20.20 – Head and neck cancer
20.00 – 20.20 – Integrating IO in the head and neck cancer treatment – Conf. Dr. Laurenția Galeș
16:00 – 16:45 – Satellite Symposium BMS
16.00 – 16.15 –Opdivo + Yervoy, the new benchmark in the first line metastatic RCC – Dr. Daniela Zob
16.15 – 16.30 – Efficacy of Immunotherapy Regimen in the treatment of BRAF-mutant advanced melanoma – Conf. Dr. Laurentia Gales
16.30 – 16.45 – Opdivo®: a therapeutic strategy and a validated treatment algorithm for patients with metastatic NSCLC – Dr. Mircea Dediu
16:45 – 17:15 – Satellite Symposium Roche – New perspectives in oncology – 2020 Updates – Conf. Dr Laurenția Galeș
17.15-18.45 Prostate cancer – Moderator: Prof. Dr. Gabriel Kacso
17.15 – 17.45 – PSA rising scenario – Dr. Mircea Dediu
17.45 – 18.15 – Radiation therapy in the rising PSA scenario – Prof. Dr. Gabriel Kacso
18.15 – 18.45 –Robotic Surgery in prostate cancer – Prim. Dr. Wolfgang Loidl
18.45 – 19.00 – BREAK
19.00 – 20.30 – Other genitourinary cancers – Moderator: Prof. Dr. Lucian Miron
19.00 – 19.30 – Right sequence of therapy for metastatic RCC – Univ. Prof. Dr. Manuela Schmidinger
19.30 – 20.00 – The role of surgery in RCC – Prof. Dr. Viorel Jinga
20.00 – 20.25 – Defining the risk groups in testicular cancer – is adjuvant treatment necessary in early stages? – Prof. Dr. Lucian Miron
20.25 – 20.45 – Integrating IO in metastatic urotelial cancer – Dr. Luiza Șerbănescu
17.00-18.30 – Malignant melanoma – Moderators: Conf. Dr. Serban Negru, Conf. Dr. Laurentia Gales
17.00 – 17.30 – Adjuvant treatment in malignant melanoma – Prof. Dr. Med. Dirk Schadendorf
17.30 – 18.00 – Standard surgery approach in localized melanoma – Prof. Dr. Ioan Lascăr
18.00 – 18.30 – IO or targeted therapy or both? in advanced malignant melanoma – Conf. Dr. Șerban Negru
18.30 – 18.45 – BREAK
18:45 – 19:45 – Satellite Symposium Astra Zeneca
18:45 – 19:05 – The new therapeutic standard in SIII NSCLC. NOW is the time! – Prof. Dr. Rodica Anghel
19:05 – 19:25 – NOW is the time for better results in patients with EGFR-mutated advanced NSCLC – Dr. Andrei Ungureanu
19:25 – 19:45 – Ovarian cancer patients management: How do we do it? – Prof. Dr. Laura Mazilu.
20.00 – 21.30 – Molecular pathology and sarcoma – Moderator: Prof. Dr. Thomas Brodowicz
20.00 – 20.30 – Molecular pathology in soft tissue tumors – Univ. Prof. Dr. Bernadette Liegl-Atzwanger
20.30 – 21.00 – The role of radiation therapy in sarcoma – Dr. Mihai Georgescu
21.00 – 21.30 – Basic and principles of sarcoma treatment – Prof. Dr. Thomas Brodowicz
15:45 – 16:15 – Satellite Symposium Janssen – How to identify the nmCRPC patients eligible for novel hormone therapies? – Conf. Dr. Laurentia Gales
16:15 – 17:00 – Satellite Symposium Pfizer
16:15 – 16:40 – Optimizing outcomes in ABC HR+/HER2- patients treatment: Clinical benefits of CDK4/6i class, real practice and patient-centric approach – Conf Dr Laurentia Nicoleta Gales
16:40 – 17:00 – Benefits of Lorviqua (lorlatinib) in ALK-positive NSCLC – Prof. Dr. Tudor Eliade Ciuleanu
17.00-18.30 Colon cancer – Moderator: Dr. Razvan Curca
17.00 – 17.30 – Adjuvant setting – duration and type of chemotherapy – Dr. Răzvan Curcă
17.30 – 18.00 – Optimal Sequencing of treatment in MCRC (Chemo, BRAF, IO, VEGFR, EGFR) – Prof. Dr. Gerald Prager
18.00 – 18.30 –Correct surgical management of liver metastases in MCRC: when/why/how often – Univ. Prof. Dr. Klaus Kaczirek
18.30 – 18.45 – BREAK
18.45 – 20.15 – Lung cancer – Moderator: Prof. Dr. Tudor Eliade Ciuleanu, Asist. Univ. Dr. Radu Mitrică.
18.45 – 19.15 – Update on first line immune therapy – Prof. Dr. Tudor Eliade Ciuleanu
19.15 – 19.45 – EGFR targeted treatment in Lung Cancer: Update State of the Art and Future Directions– Prof. Dr. Martin Filipits
19.45 – 20.15 – Radiation therapy and immunotherapy in stage III lung cancer – Asist. Univ. Dr. Radu Mitrică